Increlex is a liquid that contains man-made insulin-like growth factor-1 (rhIGF-1). Thanks to advances in technology, recombinant IGF-1 is just like naturally produced IGF-1, and works in the exact the same way.

For caregivers, children, and pediatric endocrinologists, Increlex offers a true breakthrough: it is the first approved therapy in the United States for the long-term treatment of growth failure in children with severe Primary IGFD.

Email the Increlex website to a friend       Print this page